The 2025 Healthcare M&A Landscape

The 2025 Healthcare M&A Landscape

Epicea Auditorium

Information

At the end of Q1, what does the rest of 2025 have in store for the deal environment across EMEA? What are the options for exits? Who will budge first when it comes to valuation expectations and what is the impact of a changing interest rates and inflation on the back of multiple elections and geopolitical risks in key global markets.

Rothschild & CoRothschild Meeting Suite - C29+C31Rothschild & Co is one of the world’s largest independent financial advisory groups, with 4,200 people in over 40 countries worldwide. Our Global Advisory business has an impartial and insightful perspective on M&A, strategy and financing advisory to help our clients formulate and achieve their strategic goals.We are one of the most active advisers to the Healthcare sector globally and the most active in Europe.  This provides our dedicated healthcare team of over 35 bankers in London with exceptional insight into the sector, and the experience to advise on the most complex transactions.

Documents & Links

The 2025 Healthcare M&A Landscape, Hedley Goldberg, Rothschild & Co

Registered attendees

Ana-Maria Pascu
Ana-Maria Pascu
M&A DirectorRegina Maria
Anne-Laure Meynier
Anne-Laure Meynier
PartnerApposite Capital LLP
BS
Brent Stackhouse
Managing DirectorMount Sinai Ventures

Log in

See all the content and easy-to-use features by logging in or registering!